Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study in the Treatment of Anemia With Weekly Epoetin Alfa Doses in Patients With Solid Tumors or Lymphoma Receiving Chemotherapy

NCT01374373 is registered in ClinicalTrials.gov with Bio Sidus SA as lead sponsor.

NCT NCT01374373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01374373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study in the Treatment of Anemia With Weekly Epoetin Alfa Doses in Patients With Solid Tumors or Lymphoma Receiving Chemotherapy
Lead sponsor
Bio Sidus SA
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
November 30, 2014
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastic chemotherapy induced anemia